Package 78206-202-01

Brand: tofidence

Generic: tocilizumab
NDC Package

Package Facts

Identity

Package NDC 78206-202-01
Digits Only 7820620201
Product NDC 78206-202
Product ID 78206-202_2fe7ea85-3cb6-4855-9f6e-719611650564
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (78206-202-01) / 20 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2025-07-03
Brand tofidence
Generic tocilizumab
Sample Package No

Linked Drug Pages (1)

TOFIDENCE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2fe7ea85-3cb6-4855-9f6e-719611650564", "openfda": {"nui": ["N0000190478", "N0000190480"], "unii": ["I031V2H011"], "rxcui": ["2680287", "2680294", "2680296", "2680297", "2680298", "2680299"], "spl_set_id": ["1ab3207a-ebfe-4565-9ce5-3a1538815c83"], "pharm_class_epc": ["Interleukin-6 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Interleukin 6 Receptor Antagonists [MoA]"], "manufacturer_name": ["Organon LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (78206-202-01)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "78206-202-01", "marketing_start_date": "20250703"}], "brand_name": "TOFIDENCE", "product_id": "78206-202_2fe7ea85-3cb6-4855-9f6e-719611650564", "dosage_form": "INJECTION", "pharm_class": ["Interleukin 6 Receptor Antagonists [MoA]", "Interleukin-6 Receptor Antagonist [EPC]"], "product_ndc": "78206-202", "generic_name": "TOCILIZUMAB", "labeler_name": "Organon LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TOFIDENCE", "active_ingredients": [{"name": "TOCILIZUMAB", "strength": "400 mg/20mL"}], "application_number": "BLA761354", "marketing_category": "BLA", "marketing_start_date": "20250703", "listing_expiration_date": "20261231"}